Loading candles…
Parmax Pharma Ltd, incorporated in 1994 and headquartered in Gujarat, India, operates in the pharmaceuticals, life sciences, and chemicals industries. The company is engaged in manufacturing bulk drugs, drug intermediates, and specialty chemicals that serve as chemical components and active ingredients for pharmaceutical formulations. Its manufacturing operations are centralized at a facility in Hadamtala, Rajkot, focusing on medicinal chemistry and organic synthesis. Parmax Pharma Ltd primarily conducts its business within India and does not have publicly listed shares or noted subsidiaries.
This page is a live market overview for Parmax Pharma Limited (PARMAX) on the BSE. As a listed security, Parmax Pharma Limited is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for PARMAX before placing trades on tick2trade.
As of the latest feed, PARMAX last traded at ₹106.75 on BSE, up ₹2.05 (1.96%) from the previous close of ₹104.7. Today's session range is ₹106 – ₹106.75, against a 52-week band of ₹29.3 – ₹106.75. Traded volume today stands at 828 shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for PARMAX in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether PARMAX is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Parmax Pharma Limited before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in PARMAX. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated PARMAX option chain page linked from this overview.
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.